Contribution of Different Scintigraphic Techniques to the Management of Medullary Thyroid Carcinoma by Sandrock, Dirk et al.
Henry Ford Hospital Medical Journal 
Volume 37 Number 3 Article 26 
9-1989 
Contribution of Different Scintigraphic Techniques to the 
Management of Medullary Thyroid Carcinoma 
Dirk Sandrock 
Hans-Christian Blossey 
Martina Steinroeder 
Dieter L. Munz 
Follow this and additional works at: https://scholarlycommons.henryford.com/hfhmedjournal 
 Part of the Life Sciences Commons, Medical Specialties Commons, and the Public Health Commons 
Recommended Citation 
Sandrock, Dirk; Blossey, Hans-Christian; Steinroeder, Martina; and Munz, Dieter L. (1989) "Contribution of 
Different Scintigraphic Techniques to the Management of Medullary Thyroid Carcinoma," Henry Ford 
Hospital Medical Journal : Vol. 37 : No. 3 , 173-174. 
Available at: https://scholarlycommons.henryford.com/hfhmedjournal/vol37/iss3/26 
This Article is brought to you for free and open access by Henry Ford Health System Scholarly Commons. It has 
been accepted for inclusion in Henry Ford Hospital Medical Journal by an authorized editor of Henry Ford Health 
System Scholarly Commons. 
Contribution of Different Scintigraphic Techniques to the Management 
of Medullary Thyroid Carcinoma 
Dirk Sandrock,* Hans-Christian Blossey,* Martina Steinroeder,* and Dieter L . Munz* 
We compared three differenl scintigraphic techniques for the localization of neck recurrences and 
metastases in seven patients wiih medullary thyroid carcinoma one monlh lo eight years after thefirst 
surgical intervention. Three successive scintigraphic studies were performed in five patients (6x3 
studies) wilhin two weeks using -"'Tl chloride, '"In-labeled F(ah'), fragments of the anti-
carcinoembryonic antigen (anti-CEA) monoclonal antibody (MoAh) BW 431131. and '"/ meta-iodo-
benzylguanidine (MIBG). Additionally. 11 studies were performed wilh the '"In-labeled MoAb 
fragment BW 431131 (seven studies) or the ''"'"Tc-labeled intact anti-CEA MoAb BW 431126 (four 
studies). The gold .standards for classifying scintigraphic resuUs were biopsy, histology, surgery, and 
cytology. Six regions were classified as positive or negalive in each study: thyroid region, four 
quadrants (lymph node regions) around the thyroid, and the region of the upper media.stinum. Of 36 
sites, ^'"Tl was true positive (TP) in seven sites, false-positive (FP) in one site, true negative (TN) in 22 
sites, andfalse-negative (FN) in six sites, resulting in a sensitivity of 54% and a specificity of 96%. '-"/ 
MIBG was TP in four sites, FP in none of the siles, TN in 23 siles, and FN in nine sites, with a 
sensitivity of 31% and a specificity of 100%. Immunoscintigraphy (102 .sites overall) was TP in 16 siles, 
FP in five siles, TN in 77 siles, and FN in four siles. resulting in a .sensitivity of 80% and a specificity of 
94%. Immunoscintigraphy with "'lnl^'"Tc anti-CEA F(ab' )2 fragment I intact antibody is superior lo 
scintigraphy with -"'Tiand '"I MIBG. (Henry Ford Hosp MedJ 1989:37:173-4) 
S everal approaches with different radiotracers have been reported for the localization and treatment of medullary 
thyroid carcinoma (MTC) (1-6) in addition to serum levels of 
calcitonin (CT) and carcinoembryonic antigen (CEA) as 
tumor markers. 
We compared different scintigraphic methods (-'"Tl, " ' I 
meta-iodo-benzylguanidine IMIBG], and immunoscintigraphy) 
for the localization of neck recurrences and metastases in pa-
tients with MTC and for the assessment of the value of immu-
noscintigraphy for the follow-up ofthese patients. 
Methods 
Seven patients with MTC were studied one month to eight 
years after first surgical intervention (usually total thyroidec-
tomy and/or neck dissection). Patients included three men and 
four women, aged 22 to 65 at the time of first scintigraphy. Six 
had a sporadic MTC and one also had a pheochromocytoma. 
Overall, 29 scintigraphic studies were performed; in five pa-
tients, six intraindividual comparisons were performed within 
two weeks with all three tracers (6 x 3 = 18 studies). Addi-
tionally, I I studies were performed using immunoscintigraphy 
alone. 
For -"'Tl studies, 74 MBq '" 'Tl chloride was given intra-
venously and scintigraphic images obtained 10 to 90 minutes 
postinjection. Twenty-six MBq " ' I MIBG were injected intra-
venously, and scintigraphy was performed one. two, and, if nec-
essary, five days postinjection. For immunoscintigraphy, we 
used 185 MBq '"In-labeled F(ab'), fragments of the anti-CEA 
monoclonal antibody BW 431/31 intravenously with scintigra-
phy one and two days postinjection (13 studies) or 740 MBq 
""Tc-labeled intact anti-CEA monoclonal antibody BW 431/26 
with scintigraphy 4.5 and 24 hours postinjection (four studies). 
Studies using emission computed tomography were also done i f 
appropriate. 
In each study, six regions were classified as positive or nega-
five; thyroid region, four lymph node quadrants around the thy-
roid, and the upper mediastinal region. The gold standards for 
classification as true or false positive/negative were biopsy, sur-
gery, histology, or cytology. Computed tomography or ultra-
sonography demonstrated partly normal, partly equivocal 
findings. 
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Table 
Results of Scintigraphy in Medullary Thyroid Carcinoma 
Tracer Siles TP FP TN FN Sensitivity Specificity 
»'T1 chloride 36 7 1 22 6 54% 96% 
" ' I MIBG 36 4 t) 23 9 31% 100% 
"'In. 'Jc MoAb 102 16 5 77 4 80% 94% 
TP = true positive, FP = false-positive, TN - tnie negative, and FN = false-
negative. 
Results 
Overall, 13 of 36 regions (^"'TI, MIBG studies) were positive 
with tumor recurrence or lymph node metastases as proven by 
histology or cytology. In the larger group with immunoscin-
tigraphic studies, 20 of 102 regions were tumor positive; eight 
local recunences in the thyroid area, four lymph node metasta-
ses in the upper quadrant (cervical), six lymph node metastases 
in the lower quadrant (lower jugular vein and supraclavicular), 
and two lymph node metastases in the upper mediastinum. The 
size of the tumor deposits detected by scintigraphy ranged from 
1.5 to 4 cm in diameter At time of first study, seram CEA was 
elevated in four patients, normal in two patients, and not avail-
able in one patient. CT was positive in tliree patients, negative in 
three patients, and not available in one patient. 
Immunoscintigraphy detected 16 sites correctly (true 
positive) and missed four sites (false-negative). A total of 77 
sites were classified as true negative, and five false-positive 
spots were seen. In att parients with false-negative or false-
positive spots, at least one trae positive site was detected. 
With -"'Tl chloride, seven sites were tme positive and six were 
false-negative. Twenty-two regions were trae negative and one 
spot was false-positive. Using ' " I MIBG, only four sites were 
trae positive while nine sites were missed (false-negative). Atl 
23 sites were trae negative (no false-positive). The Table gives 
the appropriate numbers and the sensitivity and specificity 
values. 
Immunoscintigraphy with '"In-labeled anti-CEA F(ab')2 
fragments or ""Tc-Iabeled intact anti-CEA monoclonal anti-
body is superior to scintigraphy with -"'Tl chloride and " ' I 
MIBG. 
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